EGFR and colorectal carcinoma: Irregular phosphorylation patterns frequently act as biomarkers for diagnosing and developing treatment plans; crucial pathways involved include the activation of kinases such as Src, EGFR, and PI3K, which results in the phosphorylation of specific tyrosine residues on target proteins, significantly influencing CRC progression [63–65].